Flora Growth Corp. (FLGC)
USD 0.48
(-2.3%)
USD 0.48
(-2.3%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 23.62 Million USD | -70.83% |
| 2022 | 80.98 Million USD | -5.26% |
| 2021 | 85.47 Million USD | 339.44% |
| 2020 | 19.45 Million USD | 1558.49% |
| 2019 | 1.17 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 24.27 Million USD | 2.74% |
| 2024 Q2 | 30.08 Million USD | 23.93% |
| 2023 FY | 23.62 Million USD | -70.83% |
| 2023 Q3 | 31.6 Million USD | 3.68% |
| 2023 Q1 | 77.04 Million USD | -4.87% |
| 2023 Q4 | 23.62 Million USD | -25.23% |
| 2023 Q2 | 30.47 Million USD | -60.44% |
| 2022 Q4 | 80.98 Million USD | 10.74% |
| 2022 Q3 | 73.13 Million USD | -7.5% |
| 2022 Q1 | - USD | -100.0% |
| 2022 Q2 | 79.06 Million USD | 0.0% |
| 2022 FY | 80.98 Million USD | -5.26% |
| 2021 Q1 | - USD | -100.0% |
| 2021 FY | 85.47 Million USD | 339.44% |
| 2021 Q2 | 30.25 Million USD | 0.0% |
| 2021 Q4 | 85.47 Million USD | 0.0% |
| 2020 Q4 | 19.45 Million USD | 0.0% |
| 2020 Q3 | 19.45 Million USD | 109.26% |
| 2020 Q2 | 9.29 Million USD | 0.0% |
| 2020 Q1 | - USD | 0.0% |
| 2020 FY | 19.45 Million USD | 1558.49% |
| 2019 FY | 1.17 Million USD | 0.0% |
| 2019 Q2 | 238.00 USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Cosmos Health Inc. | 66.29 Million USD | 64.363% |
| Safety Shot Inc | 12.7 Million USD | -85.897% |
| Bright Green Corporation | 17.4 Million USD | -35.758% |
| Embecta Corp. | 1.21 Billion USD | 98.055% |
| ANI Pharmaceuticals, Inc. | 904.42 Million USD | 97.388% |
| Aquestive Therapeutics, Inc. | 57.41 Million USD | 58.853% |
| Collegium Pharmaceutical, Inc. | 1.14 Billion USD | 97.934% |
| Dynavax Technologies Corporation | 997.09 Million USD | 97.631% |
| Esperion Therapeutics, Inc. | 205.79 Million USD | 88.52% |
| Intra-Cellular Therapies, Inc. | 728.29 Million USD | 96.756% |
| Pacira BioSciences, Inc. | 1.57 Billion USD | 98.499% |
| PainReform Ltd. | 9.93 Million USD | -137.925% |
| Sunshine Biopharma, Inc. | 27.34 Million USD | 13.606% |
| Sunshine Biopharma, Inc. | 27.34 Million USD | 13.606% |
| SCYNEXIS, Inc. | 128.41 Million USD | 81.601% |
| China SXT Pharmaceuticals, Inc. | 23.12 Million USD | -2.157% |
| Journey Medical Corporation | 76.84 Million USD | 69.257% |
| Alpha Teknova, Inc. | 128.58 Million USD | 81.626% |
| Procaps Group, S.A. | 460.18 Million USD | 94.866% |
| Theratechnologies Inc. | 77.76 Million USD | 69.62% |
| Harrow Health, Inc. | 311.75 Million USD | 92.422% |
| Sonoma Pharmaceuticals, Inc. | 14.89 Million USD | -58.638% |
| Biofrontera Inc. | 27.93 Million USD | 15.416% |
| DURECT Corporation | 45.18 Million USD | 47.717% |
| Supernus Pharmaceuticals, Inc. | 1.4 Billion USD | 98.323% |
| Cronos Group Inc. | 1.13 Billion USD | 97.917% |
| OptiNose, Inc. | 107.72 Million USD | 78.069% |
| Ironwood Pharmaceuticals, Inc. | 471.07 Million USD | 94.985% |
| Kala Pharmaceuticals, Inc. | 55.94 Million USD | 57.772% |
| RedHill Biopharma Ltd. | 23.04 Million USD | -2.512% |
| Organogenesis Holdings Inc. | 460.02 Million USD | 94.864% |
| Guardion Health Sciences, Inc. | 11.91 Million USD | -98.235% |
| Cumberland Pharmaceuticals Inc. | 81.77 Million USD | 71.109% |
| Radius Health, Inc. | 1.71 Billion USD | 98.623% |
| Universe Pharmaceuticals INC | 53.28 Million USD | 55.663% |
| ProPhase Labs, Inc. | 91.92 Million USD | 74.299% |
| Phibro Animal Health Corporation | 982.18 Million USD | 97.595% |
| Procaps Group S.A. | 460.18 Million USD | 94.866% |
| Alvotech | 950.09 Million USD | 97.513% |
| TherapeuticsMD, Inc. | 43.3 Million USD | 45.448% |
| Viatris Inc. | 47.68 Billion USD | 99.95% |
| Rockwell Medical, Inc. | 52.17 Million USD | 54.716% |
| Aytu BioPharma, Inc. | 118.09 Million USD | 79.994% |
| SIGA Technologies, Inc. | 254.83 Million USD | 90.729% |
| Tilray Brands, Inc. | 4.33 Billion USD | 99.455% |
| Lifecore Biomedical, Inc. | 273.7 Million USD | 91.368% |
| Shineco, Inc. | 84.17 Million USD | 71.934% |
| PetIQ, Inc. | 868.22 Million USD | 97.279% |
| Regencell Bioscience Holdings Limited | 8.43 Million USD | -179.988% |
| Incannex Healthcare Limited | 17.04 Million USD | -38.593% |
| Neurocrine Biosciences, Inc. | 3.25 Billion USD | 99.273% |
| Alimera Sciences, Inc. | 153.52 Million USD | 84.611% |
| Silver Spike Investment Corp. | 88.57 Million USD | 73.327% |
| Assertio Holdings, Inc. | 286.41 Million USD | 91.751% |
| Shuttle Pharmaceuticals Holdings, Inc. | 5.95 Million USD | -296.96% |
| Petros Pharmaceuticals, Inc. | 33.79 Million USD | 30.092% |
| Clever Leaves Holdings Inc. | 31.24 Million USD | 24.38% |
| Cyclo Therapeutics, Inc. | 13.24 Million USD | -78.343% |
| Avadel Pharmaceuticals plc | 261.12 Million USD | 90.952% |
| Hempacco Co., Inc. | 18.04 Million USD | -30.942% |
| Talphera, Inc. | 20.39 Million USD | -15.842% |
| Alvotech | 950.09 Million USD | 97.513% |
| Eagle Pharmaceuticals, Inc. | 406.16 Million USD | 94.183% |
| Lantheus Holdings, Inc. | 1.65 Billion USD | 98.569% |
| Currenc Group, Inc. | 141.49 Million USD | 83.302% |
| Kamada Ltd. | 351.96 Million USD | 93.287% |
| Indivior PLC | 1.95 Billion USD | 98.789% |
| Evoke Pharma, Inc. | 7.06 Million USD | -234.241% |
| Cyclo Therapeutics, Inc. | 13.24 Million USD | -78.343% |
| Evolus, Inc. | 188.99 Million USD | 87.499% |
| HUTCHMED (China) Limited | 1.27 Billion USD | 98.154% |
| Amphastar Pharmaceuticals, Inc. | 1.51 Billion USD | 98.438% |
| Akanda Corp. | 8.83 Million USD | -167.263% |